TOKYO (Reuters) - Japan's Dainippon Sumitomo Pharma Co said on Wednesday that it will buy U.S.-based Boston Biomedical Inc for $200 million to expand its cancer treatment business and extend its global reach. The Osaka-based drugmaker also sai...
Source: http://health.yahoo.net/news/s/nm/dainippon-to-buy-u-s-bio-venture-in-cancer-drug-push
writing Jesus Receipt design John Edwards
No comments:
Post a Comment
Note: only a member of this blog may post a comment.